ES556292A0 - Un procedimiento para la preparacion del acido 5(-)-9-halogeno-3-alquil-10-(4-alquil-1-piperazimil)-7-oxo-2,3-dihidro-7h-piriolo (1,2,3,-de)-1,4 benzoxalin-6-carboxilico. - Google Patents

Un procedimiento para la preparacion del acido 5(-)-9-halogeno-3-alquil-10-(4-alquil-1-piperazimil)-7-oxo-2,3-dihidro-7h-piriolo (1,2,3,-de)-1,4 benzoxalin-6-carboxilico.

Info

Publication number
ES556292A0
ES556292A0 ES556292A ES556292A ES556292A0 ES 556292 A0 ES556292 A0 ES 556292A0 ES 556292 A ES556292 A ES 556292A ES 556292 A ES556292 A ES 556292A ES 556292 A0 ES556292 A0 ES 556292A0
Authority
ES
Spain
Prior art keywords
alkyl
piriolo
piperazimil
benzoxalin
carboxilico
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556292A
Other languages
English (en)
Other versions
ES8801251A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27281433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES556292(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP60226499A external-priority patent/JPH0720946B2/ja
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of ES8801251A1 publication Critical patent/ES8801251A1/es
Publication of ES556292A0 publication Critical patent/ES556292A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES556292A 1985-06-20 1986-06-19 Un procedimiento para la preparacion del acido 5(-)-9-halogeno-3-alquil-10-(4-alquil-1-piperazimil)-7-oxo-2,3-dihidro-7h-piriolo (1,2,3,-de)-1,4 benzoxalin-6-carboxilico. Expired ES8801251A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13471285 1985-06-20
JP60226499A JPH0720946B2 (ja) 1985-10-11 1985-10-11 光学活性３−メチルベンゾオキサジン誘導体およびその製法
JP1649686 1986-01-28

Publications (2)

Publication Number Publication Date
ES8801251A1 ES8801251A1 (es) 1988-01-01
ES556292A0 true ES556292A0 (es) 1988-01-01

Family

ID=27281433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556292A Expired ES8801251A1 (es) 1985-06-20 1986-06-19 Un procedimiento para la preparacion del acido 5(-)-9-halogeno-3-alquil-10-(4-alquil-1-piperazimil)-7-oxo-2,3-dihidro-7h-piriolo (1,2,3,-de)-1,4 benzoxalin-6-carboxilico.

Country Status (16)

Country Link
US (3) US5053407A (es)
EP (1) EP0206283B1 (es)
KR (2) KR920010048B1 (es)
AT (1) ATE85057T1 (es)
BG (1) BG60527B2 (es)
CA (1) CA1304080C (es)
DE (2) DE3687599T2 (es)
DK (1) DK170473B1 (es)
ES (1) ES8801251A1 (es)
FI (1) FI90241C (es)
GR (1) GR861625B (es)
HK (1) HK91793A (es)
IE (1) IE59463B1 (es)
NL (1) NL980016I2 (es)
NO (1) NO166131C (es)
YU (3) YU44918B (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE110061T1 (de) * 1986-12-25 1994-09-15 Daiichi Seiyaku Co Optisch aktive 2,3-dihydrobenzoxazinderivate und verfahren zu deren herstellung.
IE75342B1 (en) * 1987-12-25 1997-08-27 Daiichi Seiyaku Co Propoxybenzene derivatives and process for preparing the same
MY104139A (en) * 1988-08-09 1994-02-28 Daiichi Seiyaku Co Antimicrobial agent for animals
US5175160A (en) * 1988-08-09 1992-12-29 Daiichi Pharmaceutical Co., Ltd. Antimicrobial agent for animals
AU4376589A (en) * 1988-11-07 1990-05-10 Gist-Brocades N.V. Optically active benzoxazines and benzothiazines
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
TW208013B (es) * 1990-03-01 1993-06-21 Daiichi Co Ltd
FI96313C (fi) * 1990-11-28 1996-06-10 Daiichi Seiyaku Co Menetelmä terapeuttisesti käyttökelpoisten ja optisesti aktiivisten 10-(3-amino-4,4-dialkyyli-1-pyrrolidinyyli)-9-fluori-2,3-dihydro-3(S)-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojen valmistamiseksi
ES2055656B1 (es) * 1992-10-07 1995-11-16 Etilo Derivados Procedimiento para la obtencion de benzoxazinas utiles para sintesis de ofloxacina, levofloxacina y derivados.
WO1994007873A1 (es) * 1992-10-07 1994-04-14 Derivados Del Etilo, S.A. Prodedimiento para la obtencion de benzoxazinas utiles para la sintesis de ofloxacina, levofloxacina y derivados
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
US5972358A (en) * 1998-01-20 1999-10-26 Ethicon, Inc. Low tack lotion, gels and creams
US5997893A (en) * 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
KR100309871B1 (ko) 1999-02-24 2001-10-29 윤종용 (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법
WO2000032196A2 (en) 1998-12-04 2000-06-08 Influx, Inc. Inhibitors of multidrug transporters
KR100617952B1 (ko) * 1999-03-04 2006-08-30 보령제약 주식회사 광학활성 피리도 벤즈옥사진 유도체의 제조방법
EP2284174B1 (en) * 1999-09-08 2014-03-05 Daiichi Sankyo Company, Limited Intermediates for the preparation of benzoxazine derivatives and process for their preparation
KR20010103346A (ko) * 2000-05-09 2001-11-23 이후근 패각 입자와 접착제 그리고 물감을 혼합하여 그림 밑칠용재료를 제조하는 방법
CA2424402A1 (en) 2000-12-21 2002-08-01 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
KR100868619B1 (ko) 2001-03-07 2008-11-13 다이이찌 세이야꾸 가부시기가이샤 광학활성인 프로폭시아닐린 유도체의 제조방법
CN1201028C (zh) 2001-04-27 2005-05-11 浦项产业科学研究院 具有优越热加工性能的高锰二联不锈钢及其制造方法
PT1451194E (pt) 2001-10-03 2007-01-31 Teva Pharma Preparação de hemi-hidrato de levofloxacina
US7425628B2 (en) * 2001-10-03 2008-09-16 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
KR100440192B1 (ko) * 2001-11-22 2004-07-12 이수화학 주식회사 광학 활성 퀴놀론카르복실산 유도체의 제조방법
AU2002365416A1 (en) * 2001-11-29 2003-06-10 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
BR0215413A (pt) * 2001-12-24 2004-12-14 Teva Pharma Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
WO2004069825A1 (en) * 2002-08-14 2004-08-19 Teva Pharmaceutical Industries Ltd. Synthesis of gatifloxacin
US20040152701A1 (en) * 2002-12-02 2004-08-05 Dr. Reddy's Laboratories Limited Novel anhydrous crystalline form of Levofloxacin and process for preparation there of
FR2859471B1 (fr) 2003-09-09 2006-02-03 Solvay Procede pour la fabrication d'un compose enantiopur
US20080194640A1 (en) 2005-02-07 2008-08-14 Mitsuharu Nakamura Optically Active Tetrahydronaphthalene Derivative
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CA2642264A1 (en) * 2006-02-13 2007-08-30 Trustees Of Boston University Reca inhibitors with antibiotic activity, compositions and methods of use
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20100234348A1 (en) * 2006-08-04 2010-09-16 Trustees Of Boston University Compositions and methods for potentiating antibiotic activity
EP1939206A1 (en) * 2006-12-22 2008-07-02 Farmaprojects, S.A. Process for the preparation of an antibacterial quinolone compound
US20100029938A1 (en) * 2006-12-22 2010-02-04 Farmaprojects, S. A. Process for the preparation of an antibacterial quinolone compound
US7964723B2 (en) 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
KR20110091510A (ko) 2008-10-07 2011-08-11 엠펙스 파마슈티컬즈, 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
EP2429991B1 (en) 2009-05-15 2014-09-10 Redx Pharma Limited Redox drug derivatives
CN101659669B (zh) * 2009-09-04 2011-07-20 诚达药业股份有限公司 左旋氧氟沙星的制备方法
RU2015130524A (ru) 2009-09-04 2018-12-21 Раптор Фармасьютикалз Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
CN102775424A (zh) * 2012-07-09 2012-11-14 浙江司太立制药股份有限公司 一种左氧氟沙星杂质的制备方法
WO2015171002A1 (en) * 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine
CN105037388A (zh) * 2015-08-28 2015-11-11 安徽环球药业股份有限公司 一种安妥沙星的制备方法
CN105367585B (zh) * 2015-12-02 2017-11-17 山东齐都药业有限公司 左氧氟沙星杂质的制备方法
US20230233572A1 (en) 2020-06-11 2023-07-27 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS5852290A (ja) * 1981-09-21 1983-03-28 Dai Ichi Seiyaku Co Ltd ピリドベンゾオキサジンカルボン酸誘導体
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln

Also Published As

Publication number Publication date
DE19875012I2 (de) 2006-06-29
YU186788A (en) 1989-04-30
EP0206283A3 (en) 1988-08-10
IE59463B1 (en) 1994-02-23
NO166131C (no) 1991-06-05
IE861631L (en) 1986-12-20
GR861625B (en) 1986-10-21
CA1304080C (en) 1992-06-23
DE3687599D1 (de) 1993-03-11
ATE85057T1 (de) 1993-02-15
EP0206283B1 (en) 1993-01-27
BG60527B2 (bg) 1995-07-28
ES8801251A1 (es) 1988-01-01
US5053407A (en) 1991-10-01
FI90241B (fi) 1993-09-30
KR870000340A (ko) 1987-02-17
YU45512B (en) 1992-05-28
NL980016I2 (nl) 1998-08-03
NL980016I1 (nl) 1998-07-01
DK170473B1 (da) 1995-09-11
US4985557A (en) 1991-01-15
YU107386A (en) 1988-02-29
FI90241C (fi) 1994-01-10
HK91793A (en) 1993-09-10
US5142046A (en) 1992-08-25
EP0206283A2 (en) 1986-12-30
KR920010048B1 (ko) 1992-11-13
FI862643A0 (fi) 1986-06-19
YU45524B (en) 1992-05-28
KR920009279A (ko) 1992-05-28
NO166131B (no) 1991-02-25
DE3687599T2 (de) 1993-05-19
YU44918B (en) 1991-04-30
DK285086D0 (da) 1986-06-18
DK285086A (da) 1986-12-21
KR940003757B1 (ko) 1994-04-30
NO862426D0 (no) 1986-06-18
NO862426L (no) 1986-12-22
FI862643A (fi) 1986-12-21
YU209889A (en) 1990-04-30

Similar Documents

Publication Publication Date Title
ES556292A0 (es) Un procedimiento para la preparacion del acido 5(-)-9-halogeno-3-alquil-10-(4-alquil-1-piperazimil)-7-oxo-2,3-dihidro-7h-piriolo (1,2,3,-de)-1,4 benzoxalin-6-carboxilico.
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
GB8334494D0 (en) Carbostyril derivatives
PT83423A (en) Process for preparation of new quinoline derivatives
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
DE3586649T2 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ES2031889T3 (es) Un procedimiento para preparar un derivado de pirido (1,2-a)pirimidina.
EP0486687A4 (en) Quinolonecarboxylic acid derivatives
ATE29257T1 (de) 2-oxoazetidinon-derivate, ihre herstellung und verwendung.
HUT38920A (en) Process for producing anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives
EP0264951A3 (en) Procaterol-derivatives
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
SU1573830A1 (ru) Фосфорилированные оксиэтиловые эфиры 2,4-дихлорфеноксиуксусной кислоты, обладающие гербицидной активностью

Legal Events

Date Code Title Description
PC1A Transfer granted
SPCF Request for supplementary protection certificate filed

Free format text: TAVANIC (LEVOFLOXACIN)

Spc suppl protection certif: C9900014

Filing date: 19990326

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20100528